OS Therapies OSTX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $22.4M+36.9% | $16.36M+94.0% | $8.43M+43.2% | $5.89M+55.5% | $3.79M+33.4% | ||
| $11.47M-7.1% | $12.34M+9.7% | $11.25M+20.3% | $9.35M+26.4% | $7.4M+86.1% | ||
| -$33.87M-18.0% | -$28.71M-45.8% | -$19.68M-29.1% | -$15.24M-36.3% | -$11.18M-64.1% | ||
| —— | —— | —— | —— | —— | ||
| -$1.4M-2,807% | -$48.14K-103% | $1.4M+45.5% | $962.08K+917% | -$117.7K+94.3% | ||
| —— | —— | —— | —— | —— | ||
| -$35.27M-22.7% | -$28.75M-57.3% | -$18.28M-28.0% | -$14.28M-26.4% | -$11.3M-27.2% | ||
| -$1.08-9.1% | -$0.99+18.9% | -$1.22-2.5% | -$1.19+5.6% | -$1.26+5.3% | ||
| -$33.39M-17.8% | -$28.34M-45.8% | -$19.44M-28.5% | -$15.13M-35.3% | -$11.18M-64.1% | ||
| -$33.87M-18.0% | -$28.71M-45.8% | -$19.68M-29.1% | -$15.24M-36.3% | -$11.18M-64.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is OS Therapies profitable?
- OS Therapies is not currently profitable: it reported a net loss of $35.3M over the trailing twelve months.
- What is OS Therapies's earnings per share?
- OS Therapies's diluted EPS over the trailing twelve months is $-1.08.
- Where does OS Therapies's income statement data come from?
- Every line is extracted from OS Therapies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.